Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

Dezima Pharma

  • Dezima Pharma
  • Gooimeer 2 - 35
  • DC Naarden , 1411

Dezima Pharma develops drugs to treat dyslipidemia, a major modifiable risk for cardiovascular disease. Its objective is to develop compounds from pre-clinical development to meaningful proof of concept in patients. Dezima will seek strategic partners to further development in the larger cardiovascular indications, and/or continue in-house development of its compounds in smaller, orphan-type indications. The Netherlands-based company was founded by Forbion Capital Partner and BioGeneration Ventures.

Related To This Company